Mechanism of isoproterenol-induced heterologous desensitization of mucin secretion from rat submandibular glands regulation of phosphorylation of Gi proteins controls the cell response to the subsequent stimulation  by Ishikawa, Yasuko et al.
ELSEVIER Biochimica et Biophysics Acta 1265 (1995) 173-180 
et Biophysics &ta 
Mechanism of isoproterenol-induced heterologous desensitization of 
mucin secretion from rat submandibular glands 
Regulation of phosphorylation of Gi proteins controls the cell response 
to the subsequent stimulation 
Yasuko Ishikawa, Ichiro Arnano, Takafurni Eguchi, Hajime Ishida * 
Department of Pharmacology, Tokushima University School of Dentistry, 3 Kuramoto-cho, Tokushima-city, Tokushima 770, Japan 
Received 14 September 1994; accepted 25 October 1994 
Abstract 
Short-term treatment of ral: submandibular tissues with 10 /IM isoproterenol (IPR) resulted in reduction of mucin secretion in response 
to the agonist during further incubation, and in increases in EC,, values. This IPR-induced reduction of secretion was coupled with 
selective decreases in the number of /?-adrenoceptors in the tissues and in their affinity for agonists, as assessed by measurement of the 
specific binding of [ 3H]dihydroalprenolol. Treatment of the tissues with IPR caused a 30% decrease in IPR-stimulated adenylate cyclase 
activity and a 25% increase in the GTP binding capacity of inhibitory G proteins (Gi proteins). This IPR treatment triggered a 60% 
increase in the ability of pertussis toxin (IAP) to catalyze ADP-ribosylation of Gi proteins in the tissue membranes. Enhanced function of 
stimulatory G proteins (Gs proteins) was observed only during the first incubation of the tissues with IPR. The IAP-catalyzed 
ADP-ribosylation of Gi proteins in tissues treated with IPR was decreased by prior treatment with cyclic AMP dependent protein kinase, 
but was increased markedly by prior treatment with alkaline phosphatase. Neither IPR-induced desensitization of protein secretion nor 
increase in the IAP-catalyzed ADP-ribosylation of Gi proteins was observed in the tissues pretreated with 0.25 PM okadaic acid. These 
findings suggest that the regulation of Gi protein phosphorylation plays an important role in the IPR-induced heterologous desensitization 
of mucin secretion from rat submandibular glands. 
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protein kinase 
1. Introduction 
Desensitization mediate:d by cr- [l] or P-adrenoceptors 
[2,3] or muscarinic acetylcholine receptors [4] is induced 
by the interaction of these receptors with their agonists and 
is coupled with decreases in the numbers of these respec- 
tive receptors in mammalian tissues. In salivary glands, 
desensitization of K+ releaise in response to (Y- or P-adren- 
ergic or muscarinic cholinergic stimuli [5], and supersensi- 
tivity of salivary secretion which is developed after 
parasympathetic or sympathetic denervation [6,7] have been 
demonstrated. We have reported previously that brief ex- 
posure of rat parotid tissue:s to isoproterenol (IPR) for less 
than 10 min resulted in su.persensitivity of amylase secre- 
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tion in the tissues on the stimulation by P-agonists. This 
reaction to IPR was also coupled with increases in the 
number of j?-adrenoceptors in the tissues and in the affin- 
ity of these receptors for their agonists [8]. However, 
conversely, treatment of the tissues with IPR for more than 
20 min resulted in desensitization of amylase secretion to 
subsequent stimulation by P-agonists. These findings sug- 
gest the possibility of short-term regulation of the P-adren- 
ergic system in rat salivary glands. 
The desensitization of rat heart by long-term exposure 
to IPR has been reported to be coupled with the decrease 
in mRNA for P-adrenoceptors and the increase in the level 
of inhibitory GTP binding protein a-subunits (Gia pro- 
teins) [9]. However, no change in mRNA for stimulatory 
GTP binding protein a-subunits (Gscu proteins) was ob- 
served in the mechanisms underlying this desensitization 
[lo-161. The uncoupling of Padrenoceptors from Gs pro- 
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teins, as a result of receptor phosphorylation catalyzed by 
cyclic AMP-dependent protein kinase (PKA) or specific 
/?-adrenoceptor kinase has also been shown to be involved 
in the desensitization produced by short-term exposure to 
IPR [11,12,15,16]. However, it is not clear whether the 
changes in the levels of GTP binding proteins (G proteins) 
are involved in the mechanisms underlying the desensitiza- 
tion of cells exposed briefly to P-agonists to subsequent 
stimulation with these agonists. 
We used rat submandibular tissues as an experimental 
model system to study the mechanisms responsible for the 
desensitization of mucin secretion induced by brief expo- 
sure to IPR. Coupled with this desensitization, we found 
decreases in the number of P-adrenoceptors in the tissues 
and in the affinity of these receptors for P-agonists with a 
concomitant enhancement of Gi protein function. Gi pro- 
tein function also appeared to be controlled by their phos- 
phorylation level, suggesting that enzymatic modification 
of this phosphorylation is important in the regulation of the 
cellular response to subsequent stimulation by P-agonists. 
2. Materials and methods 
2.1. Preparation and incubation of rat submandibular 
tissues 
Submandibular glands were obtained from male Wistar 
rats (8 weeks old), given [‘4C]glucosamine (1.48 MBq/lOO 
g body weight) intraperitoneally 30 min before the experi- 
ments when necessary to synthesize radiolabeled mucin in 
the glands [17]. The glands were transferred to ice-cold 
Krebs-Ringer Tris (KRT) solution, consisting of 120 mM 
NaCl, 4.8 mM KCl, 1.2 mM KH,PO,, 1.2 mM MgSO,, 
3.0 mM CaCl,, 16 mM Tris-HCl buffer (pH 7.4) and 5 
mM glucose, aerated with 0,; Approx. 800 mg wet weight 
of tissues was obtained from two rats and then small 
fragments were prepared, as described previously [8]. Be- 
fore the experiment began, the fragments were equilibrated 
with the solution for 20 min at 37°C with shaking. About 
100 mg of fragments was incubated in 10 ml of KRT 
solution with or without 10 PM IPR (subsequently re- 
ferred to as the first incubation). After the fragments were 
thoroughly washed with normal KRT solution, they were 
transferred to normal KRT solution for 10 min at 37°C 
(rest period) and then challenged by reincubation with or 
without IPR at the same concentration (subsequently re- 
ferred to as the second incubation). In some experiments, 
the tissue fragments were preincubated for 30 min with or 
without 0.25 PM okadaic acid and then treated with IPR 
as described above. At time zero and at the end of 
incubation of the tissue fragments with or without IPR, 
aliquots of the tissue homogenate and the incubation 
medium were used to determine the [‘4C]mucin contents 
according to the method described by McPherson and 
Dormer [17]. 
2.2. Binding of radiolabeled ligands 
After the first and the second incubations, tissue frag- 
ments were suspended in 50 mM Tris-HCl buffer (pH 7.4) 
with 10 mM MgCl,, and homogenized in a Polytron 
(Kinematica, Switzerland), operated for 15 s at a dial 
setting of 5, followed by centrifugation twice to remove 
the cell supernatant. The suspension was filtered through a 
single layer of nylon bolting cloth (150 mesh) and was 
used as the tissue membranes fraction. 
P-Adrenoceptors. The final suspension was used for the 
quantitative measurement of Padrenoceptors by the 
method described previously [8]. In brief, the reaction 
mixture for the assay of P-adrenoceptors contained 880 ~1 
of the tissue suspension (250 mg protein), 100 ~1 of 
various concentrations of [ 3H]dihydroalprenolol (DHA), 
and 20 ~1 of 10 PM propranolol to displace the binding of 
the labeled ligand when necessary. The mixture was incu- 
bated for 10 min at 37°C and then passed through a 
Whatman GF/B filter, which was then washed three times 
with 5 ml of icecold 50 mM Tris-HCl buffer (pH 7.4) 
containing 10 mM MgCl,. The radioactivity remaining on 
the filter was counted and the specific binding of [ 3H]DHA 
was expressed as the difference between the radioactivity 
in the presence and absence of 10 PM propranolol. 
GTP binding activity. The binding activity of G proteins 
with [ 35S]guanosine-5’-o-(3-thiotriphosphate) (GTPy S) was 
measured by the method reported by Avissar et al. [18]. 
Tissue membranes (400 mg protein), precipitated by cen- 
trifugation after the ADP-ribosylation reaction described 
below, were suspended in 880 ~1 of 25 mM Tris-HCl 
buffer (pH 7.4) 1 mM ATP, 0.1 mM MgCl,, 1 mM 
EGTA (pH 7.4), 1 mM dithiothreitol (DTT), 100 ,ul of 
various concentrations of [35S]GTPyS (0.05-5 PM), and 
20 /_&l of 100 /_LM unlabeled 5’- 
guanylylimidodiphosphate(Gpp(NH)p) to determine non- 
specific binding. The mixture was incubated at room tem- 
perature for 15 min and the reaction was stopped by the 
addition of 5 ml of ice-cold 25 mM Tris-HCl buffer (pH 
7.4) containing 1 mM DTT (buffer A). The mixture was 
passed through a Whatman GF/B filter. The filter was 
washed three times with 5 ml of buffer A and then the 
radioactivity remaining on the filter was counted. The 
specific binding of [ 35S]GTPyS was expressed as the 
difference between the radioactivity in the presence and’ 
absence of 100 PM unlabeled Gpp(NH)p. 
Maximal binding sites (B,,,) and the dissociation con- 
stant (K,,) in binding studies were determined by Scatchard 
analysis [19] and by the method of least squares. 
2.3. ADP-ribosylation of G proteins 
ADP-ribosylation of Gs proteins was performed accord- 
ing to the method of Pyne et al. [20]. The final suspension 
(5 mg protein), suspended in 600 ~1 of the reaction 
mixture consisting of 150 mM KH,PO, (pH 7.6), 3 mM 
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D’IT, 5 PM CaCl,, 1 mM MgCl,, 7.5 mM thymidine, and 
6.7 PM [32P]NAD was incubated for 45 min at 37°C 
together with cholera toxin (CT; 66 pg) which had been 
preactivated for 10 min at 37°C with 50 mM DlT. ADP- 
ribosylation of Gi proteins was performed by the method 
of Ribeiro-Neto et al. [21]. The final suspension in 25 mM 
Tris-HCl buffer (pH 7.41, .50 mM KH,PO,, 2 mM DTI’, 1 
mM ATP, 1 mM EDTA (pH 7.4), 100 PM GTP, 10 mM 
MgCl,, 10 mM thymidine, 1 mM ADP-ribose, and 6.7 
PM [32P]NAD was incubated for 1 h at 30°C together with 
pertussis toxin (IAP; 25 pg) which had been preactivated 
for 20 min at 30°C with 5 mM ATP and 20 mM DTI. The 
ADP-ribosylation reactions were stopped by the addition 
of trichloroacetic acid (TCA) at a final concentration of 
6%. In some experiments, the reaction was stopped by the 
addition of 25 ml ice-cold 25 mM Tris-HCl buffer (pH 
7.4) and 5 mM MgCl,, and immediately centrifuged. The 
resulting pellets were then used for GTP binding experi- 
ments as described above. The mixtures were allowed to 
stand for 30 min on ice, after which they were centrifuged 
at 3000 rpm for 20 min at 4°C. The resulting pellets were 
washed with ethyl ether saturated with H,O and collected 
by centrifugation. The re:maining ether was allowed to 
evaporate. Samples were dissolved, without heating, in 960 
~1 of solubilizing buffer, consisting of 62.5 mM Tris-HCl 
(pH 6.81, 2% sodium dodesylsulfate (SDS), 10% glycerol, 
and 0.04% 3-((3-cholamido-propyl)dimethylammonio)-l- 
propanesulfonate (CHAPS), and then mixed with 50 ~1 of 
mercaptoethanol and 10 ,ul of 0.1% bromophenol blue. 
Aliquots (200 ~1 in each lane) were subjected to SDS- 
polyacrylamide gel electrophoresis (PAGE) in 10% or 
12.5% linear polyacrylamide gels. After electrophoresis, 
the bottom part of the gel containing [32P]NAD was cut 
off and the remainder of the gel was stained with 0.25% 
Amido Black 10B. The gel was destained, and the location 
and intensity of the radioactive peptides were analyzed 
with a thin layer scanner (Bertholt, Germany). The areas of 
the radioactive intensity were then measured with an im- 
age analyzer (Luzex 500, Nireco, Japan). In some experi- 
ments, the gel was autoracliographed. 
2.4. Phosphorylation of Gi proteins by protein kinase A 
Membrane proteins were phosphorylated according to 
the method of Watanabe et al. [22,26]. Briefly, final sus- 
pensions prepared from tissue fragments after the first and 
second incubations were centrifuged to precipitate the 
tissue membranes. The tissue membrane fraction (5 mg 
protein) was suspended in a phosphorylation mixture con- 
sisting of 50 mM triethanolamine-HCl buffer (pH 7.4), 10 
mM MgCl,, 1 mM EDTA (pH 7.41, and 1 mM ATP with 
PKA catalytic subunit (25 nnits), and incubated at 25°C for 
30 min. After the phosphorylation reaction was completed, 
the tissue membranes were used for the ADP-ribosylation 
reaction of Gi proteins as (described above. 
2.5. Dephosphorylation of Gi proteins by alkaline phos- 
phatase 
Membrane proteins were dephosphorylated by alkaline 
phosphatase (ALPase). The tissue membranes, prepared as 
described above, were suspended in a reaction mixture 
consisting of 50 mM Tris-HCl buffer (pH 7.51, 5 mM 
MgCl,, and 0.5 or 1.0 U of ALPase, followed by incuba- 
tion for 10 min at 30°C. After the reaction was completed, 
the membrane preparation was washed twice with 10 mM 
Tris-HCl buffer (pH 7.4) containing 5 mM MgCl, and 1 
mM D’IT by centrifugation. The resulting pellet was used 
for the ADP-ribosylation reaction of Gi proteins as de- 
scribed above. 
2.4. Other methods 
Protein was measured by the method of Lowry et al. 
[23]. Cyclic AMP in tissues was measured by radioim- 
munoassay with a Yamasa cyclic AMP assay kit (Yamasa 
Shoyu, Japan) as described previously [8]. Pi was esti- 
mated according to the method of Fiske and Subbarow 
[241. 
2.7. Materials 
[3~]~~~ (2.28 TBq,’ mmoll, [35~]G~~y~ (45 
TBq/mmol), [ 32 PINAD (1.11 TBq/mmol) and [ l4 Clglu- 
cosamine (1.66 GBq/mmol) were all obtained from New 
England Nuclear (USA). CT, PKA (catalytic subunit) and 
ALPase were purchased from Sigma (USA), IAP from 
Funakoshi (Japan) and okadaic acid from Katayama 
(Japan). 
3. Results 
3.1. Effects of IPR treatment on mucin secretion in rat 
submandibular tissues 
Treatment of the tissues with 10 PM IPR for 30 min 
(first incubation) significantly influenced mucin secretion 
during further incubation with the same concentration of 
IPR (second incubation). The EC,, values for IPR, calcu- 
lated from the values of mucin secretion for the first and 
the second incubations, were 24 and 63 nM, respectively, 
indicating that the secretory response to IPR during the 
second incubation was low. The amount of mucin secreted 
from the tissues which had been pretreated with 10 PM 
IPR showed a 50% decrease during the second incubation 
with 10 PM IPR in comparison with that secreted in the 
presence of the same concentration of IPR from the tissues 
which had not been pretreated with IPR (Fig. 1A). Fig. 1A 
also shows that the tissues that had been pretreated with 10 
PM IPR showed the same response during the second 
incubation in the absence of IPR as that of the tissues 
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Fig. 1. Effects of the first incubation with IPR on mucin secretion in rat 
submandibular tissues during the second incubation. Submandibular tis- 
sue fragments from rats previously given [14C]glucosamine to label 
mucin were equilibrated with KRT. They were incubated for 30 min in 
the absence (0) or presence (0) of 10 PM IPR (first incubation) and 
then incubated for 10 min in the absence of IPR (rest period). In A, the 
fragments which had been treated with 10 /.LM IPR during the first 
incubation were treated again with (0) or without (a) 10 PM IPR 
during the second incubation. In B, the fragments which had been treated 
without IPR during the first incubation were treated with (0) or without 
(0) 10 PM IPR during the second incubation. At time zero and after the 
times described in A,B, aliquots of the tissue homogenate and the 
incubation medium were used to determine the [14C]mucin contents 
according to the method described by McPherson and Dormer [17]. The 
amount of [‘4C]mucin secreted into the medium is expressed as a 
percentage of the total amount of radiolabeled mucin measured as de- 
scribed in the text. Each point represents the mean values of five 
experiments + SD. 
which had been pretreated without IPR. However, the 
secretory response to IPR of the tissues which had been 
pretreated without IPR was markedly enchanced by 10 
PM IPR during the second incubation (Fig. 1B). The total 
amount of radiolabeled mucin did not change during the 
first and second incubations with or without 10 PM IPR 
(data not shown). The decrease in the secretory response to 
IPR of the tissues which had been pretreated with the 
agonist during the second incubation did not depend on the 
duration of the reaction in the first incubation. A period of 
less than 10 min for the first incubation with IPR did not 
enhance the secretory response of the tissues to IPR, in 
contrast to the results obtained in rat parotid tissues re- 
ported previously [S]. 
3.2. Effects of IPR treatment on @adrenoceptors 
submandibular tissues 
in rat 
Changes in amounts of /3-adrenoceptors. [ 3H]D~ 
bound specifically to tissue membranes prepared after the 
first and the second incubations with or without 10 PM 
IPR. The saturable binding of [3~]~~ to the membranes 
was dose-dependent and Scatchard analysis indicated that 
the binding sites were a single population. Pretreatment 
with IPR decreased the B,,, values in the tissues from 
162 f 2 to 140 k 1 fmol/mg protein after the second 
incubation with IPR (Fig. 2). 
Changes in /3-adrenoceptor affinity. Changes in the 
affinities of /3-adrenoceptors for the agonist and the antag- 
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Fig. 2. Binding of i3H]DHA to preparations obtained from control and IPR-treated rat submandibular tissues. Rat submandibular tissues were incubated 
with (A) or without (0) 10 PM IPR for 10 min at 37°C. After incubation with fresh KRT for 10 min at 37”C, they were incubated again with (A) or 
without (0) 10 PM IPR and were then washed thoroughly with cold RRT to obtain the tissue membrane fraction. The membranes were suspended in 50 
mM Tris-HCl buffer (pH 7.4) with 10 mM MgCl, and used for the [3~]~~ binding experiment. A typical pattern of the effects of IPR treatment on 
binding of i3HlDHA to the tissues is shown. Left, saturation curve. Right, Scatchard plot of data in left. Inset: B,,, and K,, values (the mean values of 
four experiments + SD.) in the tissues after the first (1st) and second (2nd) incubations with (IPR) or without (Control) 10 /.LM IPR. 
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onist after IPR treatment were examined by measuring the 
capacity of these agents to displace bound [ 3H]DHA in 
IPR-treated and control tissues. The IC,, value (the con- 
centration for 50% inhibition) of IPR for specific binding 
of [3H]D~ in the tissues was 195 f 17 nM after the first 
incubation with IPR, but increased to 68.5 + 73 nM after 
the second incubation. Tlhere was no difference between 
these values in the control tissues after the first and the 
second incubations. In contrast to IPR, propranolol, a 
P-antagonist, caused no significant change in the IC,, 
values. 
3.3. Effects of IPR treatment on cyclic AMP content in rat 
submandibular tissues 
The cyclic AMP content in the tissues was measured 
after the first and the second incubations with or without 
IPR. A marked increase in content occurred during the first 
incubation with IPR (8.4 f 0.4 and 143.2 f 3.2 pmol/mg 
proteins in the control and IPR-treated tissues, respec- 
tively). However, after the second incubation with the 
agonist, the content was lower than that after the first 
incubation (7.0 + 0.5 and 102.3 f 4.6 pmol/mg protein in 
the control and IPR-treated tissues, respectively). This 
finding shows that the cyclic AMP content in the tissues 
was decreased by 30% after the second incubation with 
IPR. 
3.4. Effects of IPR treatment on ALIP-ribosylation of G 
proteins in rat submandibular tissues 
The ADP-ribosylation of Gs and Gi proteins in the 
tissues after the first and the second incubations with or 
without IPR was catalyzed by CT and IAP, respectively. 
No specific labeling, either in control or IPR-treated mem- 
1 2 3 4 
4 47KDa 
4 42KDa 
Fig. 3. Effects of IPR treatment on CT-catalyzed ADP-ribosylation of rat 
submandibular tissues. Membranes obtained from rat submandibular tis- 
sues after the first (1,2) and th’e second (3,4) incubations with (2,4) or 
without (1,3) 10 /.LM IPR were incubated in the reaction mixture for 
ADP-ribosylation by CT. After SDS-PAGE of CT-catalyzed ADP-ribo- 
sylation products, the gel was autoradiographed. Values for areas of 
absorbance of the bands of 42 and 47 kDa proteins in the autoradiograms 
were measured with a chromatoscanner (CS-930, Shimadzu, Japan) and 
were expressed as densitometric units per mg of protein subjected to 
electrophoresis. The numbers below are the mean values of four experi- 
ments+S.E. 42 kDa proteins: (1) 438.Ok5.6, (2) 647.5 f 15.1, (3) 
231.0+31.6, (4) 258.0+ 15.4; 47 kDa proteins: (1) 596.3 + 21.0, (2) 
615.3k27.0, (3) 439.Ok31.6, (4) 425.Ok26.8. 
(A) (6) 
41KDs 
4lKDa 
;\ 
1 
(370.3i34.3) 
Fig. 4. Typical patterns of the effects of IPR treatment on the ADP-ribo- 
sylation of Gi proteins in rat submandibular tissues. Membranes from rat 
submandibular tissues after the first (A,B) and the second (C,D) incuba- 
tions with (B,D) or without (A,C) 10 pM IPR were incubated in the 
reaction mixture for ADP-ribosylation by IAP. After SDS-PAGE of the 
ADP-ribosylation products, the location and intensity of the radioactive 
peptides on the gel were analyzed by using a thin layer scanner: The 
areas under the peaks (41 kDa) on the radiogram were then measured 
with an image analyzer. The values are expressed as mm* per mg of 
protein subjected to electrophoresis. The numbers in parentheses are the 
mean values of four experiments f S.E. 
branes, was observed in the absence of these bacterial 
toxins (data not shown). CT catalyzed ADP-ribosylation of 
two protein bands with molecular masses of 42 and 47 
kDa. IPR produced a 40% increase in the ability of CT to 
catalyze the ADP-ribosylation of the 42 kDa protein (Gs 
proteins) in the tissues after the first incubation, but had no 
effect after the second incubation (Fig. 3). Treatment with 
IPR did not affect the CT-catalyzed ADP-ribosylation of 
the 47 kDa protein. However, IAP catalyzed ADP-ribo- 
sylation of one protein band with a molecular mass of 41 
kDa (Fig. 4), and treatment of the tissues with IPR trig- 
gered a 60% increase in the ability of IAP to catalyze 
ADP-ribosylation of this 41 kDa protein (Gi proteins) after 
the second incubation with the agonist (Fig. 4C,D). There 
was no change in the ability of IAP to catalyze the 
ADP-ribosylation of Gi proteins in the tissues after the 
first incubation with or without IPR. (Fig. 4A,B). 
3.5. Effects of IPR treatment on GTP binding activity in 
rat submandibular tissues 
Submandibular tissues prepared after the first and the 
second incubations with or without IPR specifically bound 
[35~]~~~+; th e in mg was saturable within 15 min at b’ d’ 
room temperature with increased concentrations of 
[35SlGTPyS. s ca c ar analysis yielded a plot with a t h d 
single straight line, indicating a single population of bind- 
ing sites. The ADP-ribosylation of Gs and Gi proteins 
catalyzed by CT and IAP, respectively, was carried out 
before [ 35~]~~~~ binding experiments. These toxins are 
known to inactivate functionally Gs and Gi proteins by 
ADP-ribosylation of the a-subunit of these proteins [25]. 
As shown in Table 1, no IPR-induced increase in GTP 
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Table 1 
Effects of IPR treatment on GTP binding activity of Gs and Gi proteins in 
rat submandibular tissues 
Toxins B,,, (pmol/mg protein) 
First incubation Second incubation 
Control IPR Control IPR 
CT 36.Ok2.2 35.1+3.3 32.1+3.2 41.9+0.4 
(81.3 f 1.3) (76.5 +7.2) (70.3 kO.5) (75.1+ 3.2) 
IAP 29.9kO.l 36.2 + 2.0 30.0 + 1.4 31.2* 1.9 
(77.0+ 1.1) (73.8+5.2) (80.9+0.1) (75.0+0.7) 
Membranes from the tissue fragments incubated with or without 10 /.LM 
IPR, as described in Fig. 2 legend, were incubated in medium containing 
[35S]GTPyS in the presence of preactivated CT or IAP as described in the 
text. B,,, values, and K, values, shown in parentheses, are the mean of 
four experiments + SD. 
mm2/mg protein in the control tissues, 671.0 f 36.6 
mm2/mg protein in the IPR-treated tissues). On the other 
hand, the increased ability of CT to catalyze the ADP-ribo- 
sylation of Gscv proteins in the tissues during the first 
incubation with IPR was not affected by the treatment with 
PKA (data not shown). 
3.7. Effects of pretreatment of rat submandibular mem- 
branes with ALPase on their ALIP-ribosylation by IAP 
binding was observed during the first incubation following 
the CT-catalyzed ADP-ribosylation of Gs proteins. How- 
ever, during the second incubation, this binding was in- 
creased (32.1 k 3.2 pmol/mg protein in the control tis- 
sues, 41.9 f 0.4 pmol/mg protein in the IPR-treated tis- 
sues). On the other hand, following the IAP-catalyzed 
ADP-ribosylation of Gi proteins, an increase in IPR-in- 
duced GTP binding was observed during the first incuba- 
tion (29.9 f 0.1 pmol/mg protein in the control tissues, 
36.2 + 2.0 pmol/mg protein in the IPR-treated tissues), 
but not during the second incubation. 
Membranes prepared from the tissues after the first and 
the second incubations with IPR were reacted with 0.5 or 
1.0 U of ALPase and then used for the IAP-catalyzed 
ADP-ribosylation of Gicu proteins. As shown in Table 2, 
the ability of IAP to catalyze the ADP-ribosylation of Gi a 
proteins increased markedly in a manner that depended on 
the dose of the enzyme. These increases in ADP-ribosyla- 
tion were in parallel to the amount of Pi removed. This 
finding indicates that the increased incorporation of ADP- 
ribose into Gicr proteins catalyzed by IAP was due to the 
dephophorylation of Gi proteins. 
3.8. Effects of pretreatment of rat submandibular tissues 
with okadaic acid on their IAP-catalyzed ADP-ribosylation 
3.6. Effects of pretreatment of rat submandibular mem- 
branes with PKA on ALIP-ribosylation by IAP 
Membranes prepared from the tissues after the first and 
the second incubations with or without IPR were incubated 
with PKA in the presence of ATP and MgCl, to phospho- 
rylate the membrane proteins, followed by reaction in 
ADP-ribosylation medium containing [ 32 PINAD and IAP. 
There were no changes in the ability of IAP to catalyze the 
ADP-ribosylation of Gicr proteins during the first (values 
for areas of the peaks (41 kDa): 633.0 + 26.0 mm2/mg 
protein in the control tissues, 629.0 k 19.7 mm2/mg pro- 
tein in the IPR-treated tissues) and the second incubations 
(values for areas of the peaks (41 kDa): 687.0 k 17.6 
Preincubation of the tissues for 30 min with 0.25 PM 
okadaic acid abolished the increases in the ability of IAP 
to catalyze the ADP-ribosylation of Gi (Y proteins observed 
during the second incubation (values for areas of the peaks 
(41 kDa): 543.5 f 17.9 mm2/mg protein in the control 
tissues, 521.5 k 9.5 mm2/mg protein in the IPR-treated 
tisses), but had no effect on the IAP-catalyzed ADP-ribo- 
sylation of Gia proteins in the tissues during the first 
incubation (values for areas of the peaks (41 kDa): 446.6 
+ 23.1 mm’/mg protein in the control tissues, 446.0 k 
19.8 mm2/mg protein in the IPR-treated tissues). This 
result suggests that the increase in IAP-catalyzed ADP- 
ribosylation of Gicu proteins was induced by the increase 
in phosphorylation of Gicu proteins. The amounts of pro- 
tein secreted by 10 PM IPR in the tissues pretreated with 
0.25 PM okadaic acid during the first and the second 
Table 2 
Effects of dephosphorylation by ALPase of Gi proteins in rat submandibular tissues pretreated with IPR on the IAP-catalyzed ADP-ribosylation 
Treatment 
with IPR 
ALPase 
(unit) 
Values for area 
(mm*/mg protein) 
Pi removed 
( pmol/mg protein) 
First None 259.8 + 25.3 1.41 + 0.07 
incubation 0.5 491.7 * 24.4 2.96 + 0.19 
1.0 658.3 f 38.1 4.31 + 0.26 
Second None 405.5 f 30.1 1.46 f 0.03 
incubation 0.5 487.3 rt 8.0 2.77 + 0.14 
1.0 566.6 f 17.4 3.92 + 0.27 
Membranes prepared from the tissue fragments, incubated with or without 10 /.LM IPR, as described in Fig. 2 legend, were incubated with or without 
ALPase. Membranes separated by centrifugation were used for LAP-catalyzed ADP-ribosylation reaction of Gi proteins, and the supematant was used for 
the estimation of Pi removed by ALPase. After SDS-PAGE of the ADP-ribosylation products, the location and intensity of the radioactive peptides (41 
kDa) on the gel were analyzed and the values were expressed as described in Fig. 4. Values are the mean of four experiments + S.E. 
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incubations were 29.6 and 52.6 pg protein/100 mg wet 
weight of tissue, respectively, indicating that okadaic acid 
completely abolished IPR-induced desensitization of pro- 
tein secretion in the tissue. We conclude, therefore, that the 
decrease in phosphorylation of Gi proteins leads to the 
enhancement of the functilon of these proteins and plays an 
important role in the desensitization of mucin secretion in 
rat submandibular glands induced by short-term treatment 
with IPR. 
4. Discussion 
We have reported previously that brief exposure of rat 
parotid tissues to IPR, a /2agonist, resulted in an increase 
in the number of padrenoceptors, an increase in the 
affinity of these receptors for the agonist, and an increased 
amylase secretory response [8]. The supersensitivity of 
amylase secretion induced by IPR was strictly dependent 
on the reaction duration in the first incubation with the 
agonist [8]. However, in this study, the treatment of rat 
submandibular tissues with IPR reduced agonist-induced 
mucin secretion as reported by Bradbury and McPherson 
[3], and the desensitizatilon of mucin secretion was not 
dependent on the duration of the reaction during the first 
incubation of the tissues with the agonist. The number of 
/3-adrenoceptors increased1 markedly during the first incu- 
bation with IPR, but the number was decreased by 20% 
after the second incubation with the agonist (Fig. 2). The 
increases in IC,, values of IPR to displace bound [ 3H]D~ 
in tissues treated with I!PR indicated the decreases in 
affinity of @adrenoceptors for the agonist. These findings 
indicate that IPR induced a short-term down-regulation of 
P-adrenoceptors in the tissues. 
Modification of the receptor proteins, in particular their 
phosphorylation, was shown to be important in relation to 
the mechanisms that regulate desensitization in the p- 
adrenergic system. Phosphorylation of /3-adrenoceptors ei- 
ther by PKA or by a specific P-adrenergic receptor kinase, 
triggers sequestration of lthe receptors and uncoupling of 
the receptors and Gs proteins [lo-12,15,16]. Heterologous 
desensitization, such as is exhibited in IPR-induced mucin 
secretion in rat submandibular tissues, is considered to be 
triggered by phosphorylation of P-adrenoceptors by PKA, 
but not by /3-adrenergic receptor kinase [11,12,15,16]. We 
consider that, in rat subm,andibular tissues briefly exposed 
to IPR, the alterations in the number of P-adrenoceptors 
and in their affinity for the agonist that we observed in the 
present study are caused by PKA-catalyzed phosphoryla- 
tion of P-adrenoceptors. 
The cyclic AMP content in the tissues increased 
markedly during incubatilon with IPR, while the content 
after the second incubatEon with IPR was decreased by 
30%. This appears to reflect alterations in the function of 
G-proteins in the tissues dluring incubation with IPR. 
Functional modifications or decreases in the level of Gs 
protein have been suggested to be important in the mecha- 
nisms of heterologous desensitization of adenylate cyclase 
stimulation in erythrocytes [27] and hepatocytes [28]. How- 
ever, Reithman et al. [9] suggested that increases in both 
the activity and the levels of Gicu proteins served as the 
mechanism whereby noradrenaline-induced heterologous 
desensitization of adenylate cyclase stimulation occurred 
in rat heart muscle cells. This report is supported by our 
present findings that; (1) the activity and the amount of 
Gsa proteins in rat submandibular tissues were markedly 
increased only during the first incubation with IPR, but did 
not change during the second incubation with the agonist 
(Fig. 3); and (2) that the activity and the amount of Gicu 
proteins were markedly increased only during the second 
incubation with IPR, and did not change during the first 
incubation (Fig. 4). These increases in the apparent level 
of Gicu proteins, measured as IAP-catalyzed ADP-ribo- 
sylation and GTP binding capacity of Gi proteins, have 
been identified in the glucagon-induced heterologous de- 
sensitization of MDCK cell adenylate cyclase [29] and in 
the noradrenaline-induced heterologous desensitization of 
adenylate cyclase stimulation in rat heart muscle cells 
noted above [9]. The mechanisms underlying this up-regu- 
lation of Gi proteins is of great interest. 
The phosphorylation of Gi proteins catalyzed by PKA 
has been reported to result in a decrease in IAP-catalyzed 
ADP-ribosylation of these proteins within the cells, and 
this phosphorylation caused some conformational changes 
in the Gi protein trimers and decreases in both the IAP- 
catalyzed ADP-ribosylation of Gi proteins and the Mg- 
GTPy S-induced dissociation into Q- and py-subunits 
[22,26]. These findings suggest that the enhanced function 
of Gi proteins in rat submandibular tissues during the 
second incubation with IPR was induced by the impaired 
ADP-ribosylation of Gi LY proteins related to stimulation of 
their phosphorylation. This suggestion is supported by our 
findings that the increase in UP-catalyzed ADP-ribosyla- 
tion of Gicu proteins in the tissues treated with IPR was 
not observed in the tissue membranes previously phospho- 
rylated by PKA, but that it was clearly observed in these 
membranes previously dephosphorylated with ALPase (Ta- 
ble 2). We also showed that the increase in IAP-catalyzed 
ADP-ribosylation of Gicr proteins was abolished by pre- 
treatment of the rat submandibular tissues with 0.25 PM 
okadaic acid. Okadaic acid, a monocarboxylic polyether, 
inhibits protein phosphatases [30] and leads to an increase 
in protein phosphorylation in cells [31]. The IC,, values 
(concentration that produces 50% inhibition of protein 
phosphatase activity) of okadaic acid are 50 to 300 nM and 
0.1 to 2 nM for types 1 and 2A, respectively [32]. Okadaic 
acid at concentrations higher than 1 ,uM inhibited protein 
phosphatase type 2B, but had no effect on the other 
phosphatases or kinases [33]. The role of protein phospha- 
tases in the regulation of Gi proteins phosphorylation, 
therefore, appears to be important. The regulatory mecha- 
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nisms of the protein phosphatases that dephosphorylate Gi 
proteins require further investigation. 
Herein, was demonstrated that the short-term interaction 
of @adrenoceptors with a P-agonist in rat submandibular 
tissues induced phosphorylation of the receptors and Gi 
proteins by PKA during the first incubation. Subsequently, 
this same agonist triggered the dephosphorylation of Gi 
proteins by the protein phosphatase during the second 
incubation enhancing their function and finally decreasing 
the cellular response to the agonist. 
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